US92243G1085
US92243G1085
Vaxcyte, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 923.675.000 | 569.546.000 | 62.2% | |
| Operating Income | -923.675.000 | -569.546.000 | 62.2% |
| Pretax Income | -766.628.000 | -463.927.000 | 65.2% |
| Net Income Common Stockholders | -766.628.000 | -463.927.000 | 65.2% |
| -- | -- | -- | |
| -- | -- | -- |